#EndeavorBioMed
endeavorbiomedicines.com/endeavor-bio... Encouraging results from Endeavor in a Phase 2a clinical trial for Idiopathic Pulmonary Fibrosis (IPF)! With few good treatment options, it is great to see positive data. #SanDiego #Biotech #IPF #EndeavorBioMed
Endeavor BioMedicines Presents New Clinical Findings From Post Hoc Analysis of Phase 2a Clinical Trial Evaluating ENV-101 in Patients with Idiopathic Pulmonary Fibrosis | Endeavor BioMedicines
endeavorbiomedicines.com
May 21, 2025 at 5:01 PM